Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction
The Effect of Repetitive Transcranial Magnetic Stimulation on Cardiac Autonomic Dysfunction in Patients With Stroke
Afyonkarahisar Health Sciences University
44 participants
Mar 26, 2026
INTERVENTIONAL
Conditions
Summary
The aim of this study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) added to conventional neurological rehabilitation on heart rate variability (HRV), quality of life, upper extremity muscle strength and autonomic symptoms in patients with stroke.
Eligibility
Inclusion Criteria4
- Participants aged 35-80 years admitted to the Afyonkarahisar Health Sciences University Hospital Physical Medicine and Rehabilitation Unit for neurological rehabilitation after stroke
- Participants with a history of stroke of at least 3 months
- Neurologically and medically stable participants willing to participate regularly in the study
- Participants capable of following commands
Exclusion Criteria12
- Serious cardiac disease, uncontrolled hypertension
- Epilepsy or history of antiepileptic drug use
- Intracranial metallic implants
- Inner ear implants
- Malignancy
- Active infection
- Skin infection or open wound in the intervention area
- Brain lesions or medications that may alter the seizure threshold
- Increased intracranial pressure
- Uncontrolled migraine
- Fracture or surgery on the hemiplegic side within the last 6 months
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Repetitive transcranial magnetic stimulation (rTMS) will be applied using the MagVenture MagPro R30 device with a Figure Eight Coil according to the study protocol. rTMS will be delivered to the contralateral primary motor cortex (M1) upper extremity motor area at a low frequency of 1 Hz, 5 sessions per week for 4 weeks, totaling 20 sessions.
Sham (placebo) repetitive transcranial magnetic stimulation (rTMS) will be applied to mimic the procedure without delivering active stimulation. It was planned to apply it daily for 20 sessions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07482501